| Prognostically useful gene-expression profiles in acute myeloid leukemia PJM Valk, RGW Verhaak, MA Beijen, CAJ Erpelinck, ... New England Journal of Medicine 350 (16), 1617-1628, 2004 | 1497 | 2004 |
| Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia PJ Valk, RG Verhaak, MA Beijen, CA Erpelinck N Engl J Med 350 (16), 1617-28, 2004 | 428 | 2004 |
| High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients S Barjesteh van Waalwijk van Doorn-Khosrovani, C Erpelinck, ... Blood, The Journal of the American Society of Hematology 101 (3), 837-845, 2003 | 369* | 2003 |
| Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Lowenberg B, Delwel R. Prognostically useful gene-expression profiles in … PJ Valk, RG Verhaak, MA Beijen, CA Erpelinck N Engl J Med 350 (16), 1617-1628, 2004 | 250 | 2004 |
| Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML SBVW Van Doorn, C Erpelinck, J Meijer, S van Oosterhoud, ... Hematol J 4 (1), 31-40, 2003 | 231 | 2003 |
| Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11 SF Landrette, YH Kuo, K Hensen, ... Blood 105 (7), 2900-2907, 2005 | 151 | 2005 |
| Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands MJC Eijkemans, W van der Wal, LJ Reijnders, KCB Roes, ... American Journal of Kidney Diseases 66 (4), 638-645, 2015 | 128 | 2015 |
| Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage K Vanhees, S Coort, EJB Ruijters, RWL Godschalk, FJ Van Schooten, ... The FASEB Journal 25 (2), 797-807, 2011 | 104 | 2011 |
| S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 … BW van Doorn-Khosrovani Blood 101 (3), 837-45, 2003 | 85 | 2003 |
| Dietary flavonoids induce MLL translocations in primary human CD34+ cells SB van Waalwijk van Doorn-Khosrovani, J Janssen, LM Maas, ... Carcinogenesis 28 (8), 1703-1709, 2007 | 75 | 2007 |
| Dietary flavonoids induce MLL translocations in primary human CD34+ cells. BW van Doorn-Khosrovani, J Janssen, LM Maas, RW Godschalk, ... Carcinogenesis 28 (8), 1703-1709, 2007 | 70 | 2007 |
| Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia BW van Doorn-Khosrovani, D Spensberger, Y de Knegt, M Tang, ... Oncogene 24 (25), 4129-4137, 2005 | 69 | 2005 |
| Prenatal exposure to flavonoids: implication for cancer risk K Vanhees, L de Bock, RWL Godschalk, FJ van Schooten, ... Toxicological sciences 120 (1), 59-67, 2011 | 67 | 2011 |
| Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage K Vanhees, FJ van Schooten, SBW van Doorn, S van Helden, A Munnia, ... Free Radical Biology and Medicine 57, 154-161, 2013 | 62 | 2013 |
| Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood K Vanhees, RW Godschalk, A Sanders, SBW van Doorn, FJ van Schooten Toxicology 290 (2-3), 350-358, 2011 | 61 | 2011 |
| S, Spensberger D, de Knegt Y, Tang M, Lowenberg B, Delwel R. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia BW van Doorn-Khosrovani Oncogene 24 (25), 4129-4137, 2005 | 50 | 2005 |
| Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs F Vekeman, M Magestro, P Karner, MS Duh, T Nichols, ... Journal of Medical Economics 18 (12), 1060-1070, 2015 | 46 | 2015 |
| Barjesteh van Waalwijk van Doorn-Khosrovani S. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage K Vanhees, S Coort, EJ Ruijters, RW Godschalk, FJ Van Schooten, ... Faseb j 25 (2), 797-807, 2011 | 43 | 2011 |
| S, Erpelinck C, Meijer J, van Oosterhoud S, van Putten WL, Valk PJ, et al. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in … BW van Doorn-Khosrovani Hematol J 4 (1), 31-40, 2003 | 36 | 2003 |
| Khosrovani, JM Boer, HB Beverloo, MJ Moorhouse, PJ van der Spek, B. Lowenberg, and R. Delwel. Prognostically useful gene-expression profiles in acute myeloid leukemia PJ Valk, RG Verhaak, MA Beijen, CA Erpelinck, SBW van Doorn New England Journal of Medicine 350 (16), 1617-1628, 2004 | 30 | 2004 |
